Ahn-Gook Pharmaceutical Co. Ltd (001540) — Free Cash Flow Generation Index
Ahn-Gook Pharmaceutical Co. Ltd (001540) has a Free Cash Flow Generation Index of 0.81x as of September 2025. Free cash flow of ₩11.68 Billion represents 1% of operating cash flow (₩14.44 Billion). See 001540 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Ahn-Gook Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2012–2024)
Historical FCF Generation Index trend for Ahn-Gook Pharmaceutical Co. Ltd across 11 annual periods. Explore Ahn-Gook Pharmaceutical Co. Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Ahn-Gook Pharmaceutical Co. Ltd (2012–2024)
Year-by-year Free Cash Flow Generation Index for Ahn-Gook Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see 001540 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -14.53x | ₩-71.39 Billion | ₩4.91 Billion | ₩75.89 Billion | ▼ -1205.7% |
| 2022 | -1.11x | ₩-1.99 Billion | ₩1.79 Billion | ₩2.93 Billion | ▲ +55.6% |
| 2021 | -2.51x | ₩-3.69 Billion | ₩1.47 Billion | ₩4.04 Billion | ▼ -110.9% |
| 2020 | -1.19x | ₩-13.30 Billion | ₩11.19 Billion | ₩24.12 Billion | ▼ -283.6% |
| 2019 | 0.65x | ₩14.29 Billion | ₩22.08 Billion | ₩3.74 Billion | ▼ -49.2% |
| 2017 | 1.27x | ₩22.26 Billion | ₩17.46 Billion | ₩4.79 Billion | ▼ -5.4% |
| 2016 | 1.35x | ₩17.00 Billion | ₩12.62 Billion | ₩4.38 Billion | ▲ +20.1% |
| 2015 | 1.12x | ₩21.44 Billion | ₩19.11 Billion | ₩2.33 Billion | ▼ -82.9% |
| 2014 | 6.56x | ₩8.44 Billion | ₩1.29 Billion | ₩7.16 Billion | ▲ +133.5% |
| 2013 | 2.81x | ₩10.24 Billion | ₩3.64 Billion | ₩6.60 Billion | ▲ +129.6% |
| 2012 | 1.22x | ₩14.09 Billion | ₩11.51 Billion | ₩2.58 Billion | — |